Clinical Trials Browser

Phase 2 × Lymphoma, Large B-Cell, Diffuse × exifone × Clear all

NCT04479267 2025-09-29

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma

Phase 2 Active not recruiting

Lymphoma, Large B-Cell, Diffuse